Top Tech Companies (144)
Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently...
Automata was founded with a clear aim: to unlock human potential with automation. Through our collaboration with some of the world’s leading pathology labs, we’ve developed the most comprehensive lab automation platform on the market. By simplifying environments and empowering people, Automata enables labs to scale with precision and creates new opportunities for scientists to accelerate innovation
We are a global manufacturer of raw materials and a producer of energy used in everyday life. From medicines to mobile phones, agriculture to automotive, our products enhance standards of living for everyone around the world. We understand the challenge the world is facing, and we are working hard to help economies, businesses and individuals deliver a zero carbon emissions...
Mytos automates one of the last highly manual processes in biotech - growing human cells. Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data. Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists...
Copilot for clinical trials. Trained on over 700,000 clinical trials, patents and publications, neuroute Copilot turns natural language prompts into clinical development support to bring medications to patients sooner. Use Copilot to conduct market analysis, feasibility, design your clinical trial, select and review sites, find physician champions, generate documents (protocols, statistical analysis plans, SOPs), fix your enrollment, and more. Let...
To create a healthier future for patients with life-threatening diseases, we are using our pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumours. Using human in vitro models that better recreate the natural cell microenvironment is transforming our ability to identify new targets, determine mechanisms of action, and increase the success...
Pangaea Data is London and South San Francisco based provider of a software product platform to help healthcare and pharmaceutical providers to find untreated patients and bring them into screening. Such untreated patients include undiagnosed, misdiagnosed, miscoded , uncontrolled and at risk patients who comprise up-to 90% of the patient population across hard to diagnose conditions. Pangaea achieves so by...
As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities. Azelis has 4,200+ employees across 65 countries worldwide. We work with around 2,800 principals to provide a diverse range of innovative products/services to 63,000+ customers. Our industry-dedicated sales...
Our discovery platform uniquely combines target quantum mapping and AI led chemistry to enable faster development of better drug candidates. Our unique approach tackles common challenges in both AI driven drug design and target driven drug discovery. Quantum Mapping of targets introduces selectivity from the start, producing superior candidates in fewer design rounds. Identifying better starting points for AI-led chemistry...
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market...
Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies.
Entia is an oncology service provider supporting more effective cancer care by predicting and preventing treatment side effects. Our unique remote patient monitoring solutions, including the world's first at-home full blood count analyser, identify patients at risk of complications early on and enable timely interventions that can result in more time on treatment, fewer unplanned hospitalisations and the potential deliver...
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases
ENBIOSIS Biosciences reaches deep into your inner world with microbiome analysis and offers you the key for a sustainable and healthy life
At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical...
